Note that while there are compounded versions of tirzepatide and semaglutide, these drugs are not FDA approved
The treatment is especially promising for people seeking to shed pounds quickly due to obesity-related health risks tied to high blood pressure, high cholesterol, and diabetes
PLoS ONE 11 , e0147037 (2016)
Theres some evidence the supplement may be particularly helpful for people with insulin resistance who have polycystic ovary syndrome (PCOS), a hormonal condition that interferes with periods and the ovaries
Obes Pillars 15:100181 Johnson B, Milstead M, Thomas O, McGlasson T, Green L, Kreider R et al (2025) Investigating nutrient intake during use of glucagon-like peptide-1 receptor agonist: a cross-sectional study